Hematology/Oncology Grand Rounds to feature Nobel Laureate


By Roman Petrowski, Office of Communications

Dr. Aaron Ciechanover, Nobel Laureate
Aaron Ciechanover, MD, DSc, 2004 Nobel Laureate (Photo by D. Porges)

The Division of Oncology in the Department of Internal Medicine’s April edition of its “Hematology/Oncology Grand Rounds” will feature Aaron Ciechanover, MD, DSc, 2004 Nobel Laureate in Chemistry.

The presentation will be presented virtually from 8-9 a.m. April 19, via Cisco Webex.

Ciechanover will present on “The Discovery of Ubiquitin-Meditated Protein Degradation,” the topic for which he was awarded the Nobel Prize in 2004. In the early 1980s, Ciechanover along with Avram Hershko and Irwin Rose showed ubiquitin plays a key role in breaking down proteins. The ubiquitin molecule serves as a key that enters a proteasome which divides the protein into smaller pieces.

Ciechanover received his medical degree from “Hadassah” and the Hebrew University School of Medicine in Jerusalem in 1972 and a doctor of science degree from Faculty of Medicine, Technion – Israel Institute of Technology in Haifa, Israel, in 1981 following three years of service as a military physician in the Israel Defense Forces. He completed post-doctoral training in the Department of Biology and the White Institute at the Massachusetts Institute of Technology in 1984.

The Hematology/Oncology Grand Rounds serves regularly update physicians, residents, fellows, medical students, and other health care professionals, on advances in research and guidelines regarding the evaluation and multidisciplinary management of various types of cancer. The series discusses ways to integrate the information presented into clinical practice.